Skip to main content

Table 12 Incidences of any DVT (up to POD10) and major bleeding (up to POD28) in propensity-matched fondaparinux- or enoxaparin-treated groups (THA)

From: Venous thromboembolism after total joint arthroplasty: results from a Japanese multicenter cohort study

Events Fondaparinux Enoxaparin Risk ratio (95% CI) P value
n = 144 n = 144
DVT 8/144 (5.6%) 16/144 (11.1%) 0.73 (0.53-0.99) 0.134
Major bleeding 7/144 (4.9%) 0/144 (0%) - 0.022
  1. CI, confidence interval; DVT, deep vein thrombosis; POD, postoperative day; THA, total hip arthroplasty.